The prevalence of NAFLD in type 2 diabetes mellitus patients was 182.63%, 151.29%, 45.31%, 111.49%, 29%, 24.59% and 31.77% for total cholesterol, triglyceride (TG), HDL, LDL, BMI, AST and ALT, respectively. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.